Iopromide Injectable Solution bulk supplier for pharma manufacturers

Iopromide Injectable Solution 300 mg/mL, 370 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 300 mg/mL, 370 mg/mL

Reference Brands: Ultravist(US & EU)

Iopromide enhances imaging by increasing tissue radiopacity during X-ray and CT procedures. It improves visualization of blood vessels, organs, and tissues, supporting accurate diagnosis. Benefits include high-quality imaging, rapid excretion, safety, and enhanced diagnostic precision in cardiovascular, neurological, and abdominal assessments worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Iopromide injectable solution, marketed as Ultravist, is approved in the US by the FDA and in the EU via EMA for diagnostic imaging procedures, including angiography and CT scans. Regulatory approval requires comprehensive dossiers with clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe administration, and global availability, enabling high-quality imaging support for accurate diagnosis worldwide.

Iopromide Injectable Solution — third party manufacturing & bulk supply

Iopromide Injectable Solution 300 mg/mL, 370 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Iopromide Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Iopromide Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Iopromide Injectable Solution →

Back to Listing

Frequently Asked Questions

Iopromide injectable is used as a contrast agent in diagnostic imaging procedures such as CT scans, angiography, urography, and other radiographic examinations. It helps improve the visibility of blood vessels, organs, and tissues during imaging.

Iopromide is a non-ionic, water-soluble iodinated compound specifically developed for radiographic contrast imaging to enhance X-ray and CT scan images.

The most recognized trade name of iopromide injection is Ultravist.

The original brand Ultravist is manufactured by Bayer AG, and in some markets additional suppliers distribute iopromide injection under regulatory approval.

The generic name of the medicine is iopromide.

The main brand name is Ultravist.

Iopromide injection is manufactured in several countries including Germany and other European locations, as well as facilities supplying global markets under approved pharmaceutical manufacturing standards.